“…The use of sensors to monitor health forms an important component of the management of chronic diseases including diabetes and systemic hypertension, offering the potential for improved patient engagement with probable positive effects on treatment adherence. 5 Recently, an implantable device for continual IOP monitoring, the EYEMATE-IO (Implandata Ophthalmic Products GmbH, Hannover, Germany), has been developed with affirmative safety and accuracy results reported in multicenter observational studies. 6,7 The EYE-MATE-IO is a ring-shaped foldable sensor with an outer diameter of 11.3, 11.7, or 12.1 mm inserted into the ciliary sulcus during cataract surgery (Fig.…”